<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03871192</url>
  </required_header>
  <id_info>
    <org_study_id>0607-N-18</org_study_id>
    <nct_id>NCT03871192</nct_id>
  </id_info>
  <brief_title>Injections in the Diagnosis and Treatment of Lumbar Facet Syndrome</brief_title>
  <official_title>Comparison of Facet Nerve Block Versus Intra-articular Injection in the Diagnosis and Treatment of Lumbar Facet Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Complejo Hospitalario Universitario de Granada</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Complejo Hospitalario Universitario de Granada</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In suspected facet joints pain, it is recommended to perform nerve blocks to establish the
      diagnosis with positive results being and indicator of successful of most permanent treatment
      of facet pain by rhizolysis. Nevertheless, the usefulness of intraarticular joint injection
      for diagnosis and prediction of successful neurolysis have been scarcely studied. The main
      purpose of this trial is to compare both methods, nerve block and intra articular injection,
      in diagnosis and treatment of facet joints pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Facet joint pain is considered as a nonspecific cause of spinal pain with an estimated
      prevalence of 12-61% of the population. At present, there are no unanimous clinical criteria
      to achieve and accurate diagnosis and the imaging findings do not show a direct correlation
      with the clinical symptoms.

      Facet syndrome treatment is also controversial and, although most clinical guidelines
      recommend nerve block as a diagnostic test, followed by neurolysis as therapeutic technique,
      there are many detractors of this therapeutic sequence.

      The confusion is even greater when considering the variability of specialists who perform
      these techniques, the variability of methods used ranging from blind injections to injections
      guided by ultrasound, fluoroscopy or CT, or the amount of medication injected.

      The investigators have long experience in the percutaneous treatment of pain and in the use
      of different imaging techniques. Although the investigators objectives are multiple, the main
      one is to know if there are any difference in the outcome of the facet syndrome treated by
      intra-articular injections and the block of the medial branch of the dorsal branch of the
      spinal nerve.

      Along with the collaboration of other specialists the investigators want to address secondary
      objectives such as the usefulness of ultrasound and fluoroscopy in the treatment of facet
      syndrome and its comparison with those performed under CT guidance that is considered as the
      standard technique for its greater precision.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 15, 2018</start_date>
  <completion_date type="Anticipated">August 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>the patients are randomly assigned to intraarticular injection or nerve block</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>The patients and the evaluator don't know if the injection was performed inside the joint or around the nerve</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Pain (VAS score)</measure>
    <time_frame>1 year</time_frame>
    <description>score from no pain (0) to maximum pain (10)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oswestry scale</measure>
    <time_frame>1 year</time_frame>
    <description>score from no disability(0) to maximum disability (10)</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Facet Joint Pain</condition>
  <condition>Facet Syndrome of Lumbar Spine</condition>
  <condition>Facet Joints; Degeneration</condition>
  <arm_group>
    <arm_group_label>FACET JOINT UNDER CT GUIDANCE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Injection of the facet joint under computed tomography guidance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NERVE BLOCK UNDER CT GUIDANCE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Injection of the nerve under computed tomography guidance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FACET JOINT UNDER FLUOROSCOPY GUIDANCE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Injection of the facet joint under fluoroscopy guidance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NERVE BLOCK UNDER FLUOROSCOPY GUIDANCE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Injection of the nerve under ultrasound guidance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FACET JOINT UNDER ULTRASOUND GUIDANCE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Injection of the facet joint under ultrasound guidance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NERVE BLOCK UNDER ULTRASOUND GUIDANCE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Injection of the nerve under computed ultrasound guidance</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>FACET JOINT UNDER CT GUIDANCE</intervention_name>
    <description>injection of triamcinolone in the facet joint under CT guidance</description>
    <arm_group_label>FACET JOINT UNDER FLUOROSCOPY GUIDANCE</arm_group_label>
    <arm_group_label>FACET JOINT UNDER ULTRASOUND GUIDANCE</arm_group_label>
    <arm_group_label>NERVE BLOCK UNDER CT GUIDANCE</arm_group_label>
    <arm_group_label>NERVE BLOCK UNDER FLUOROSCOPY GUIDANCE</arm_group_label>
    <arm_group_label>NERVE BLOCK UNDER ULTRASOUND GUIDANCE</arm_group_label>
    <other_name>facet joint</other_name>
    <other_name>ct guidance</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>NERVE BLOCK UNDER CT GUIDANCE</intervention_name>
    <description>injection of triamcinolone around the dorsal ramus under CT guidance</description>
    <arm_group_label>FACET JOINT UNDER CT GUIDANCE</arm_group_label>
    <arm_group_label>FACET JOINT UNDER FLUOROSCOPY GUIDANCE</arm_group_label>
    <arm_group_label>FACET JOINT UNDER ULTRASOUND GUIDANCE</arm_group_label>
    <arm_group_label>NERVE BLOCK UNDER FLUOROSCOPY GUIDANCE</arm_group_label>
    <arm_group_label>NERVE BLOCK UNDER ULTRASOUND GUIDANCE</arm_group_label>
    <other_name>posterior ramus</other_name>
    <other_name>ct guidance</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>FACET JOINT UNDER FLUOROSCOPY GUIDANCE</intervention_name>
    <description>injection of triamcinolone in the facet joint under fluoroscopy guidance</description>
    <arm_group_label>FACET JOINT UNDER CT GUIDANCE</arm_group_label>
    <arm_group_label>FACET JOINT UNDER ULTRASOUND GUIDANCE</arm_group_label>
    <arm_group_label>NERVE BLOCK UNDER CT GUIDANCE</arm_group_label>
    <arm_group_label>NERVE BLOCK UNDER FLUOROSCOPY GUIDANCE</arm_group_label>
    <arm_group_label>NERVE BLOCK UNDER ULTRASOUND GUIDANCE</arm_group_label>
    <other_name>facet joint</other_name>
    <other_name>fluoroscopy guidance</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>NERVE BLOCK UNDER FLUOROSCOPY GUIDANCE</intervention_name>
    <description>injection of triamcinolone around the dorsal ramus under fluoroscopy guidance</description>
    <arm_group_label>FACET JOINT UNDER CT GUIDANCE</arm_group_label>
    <arm_group_label>FACET JOINT UNDER FLUOROSCOPY GUIDANCE</arm_group_label>
    <arm_group_label>FACET JOINT UNDER ULTRASOUND GUIDANCE</arm_group_label>
    <arm_group_label>NERVE BLOCK UNDER CT GUIDANCE</arm_group_label>
    <arm_group_label>NERVE BLOCK UNDER ULTRASOUND GUIDANCE</arm_group_label>
    <other_name>posterior ramus</other_name>
    <other_name>fluoroscopy guidance</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>FACET JOINT UNDER ULTRASOUND GUIDANCE</intervention_name>
    <description>injection of triamcinolone in the facet joint under ultrasound guidance</description>
    <arm_group_label>FACET JOINT UNDER CT GUIDANCE</arm_group_label>
    <arm_group_label>FACET JOINT UNDER FLUOROSCOPY GUIDANCE</arm_group_label>
    <arm_group_label>NERVE BLOCK UNDER CT GUIDANCE</arm_group_label>
    <arm_group_label>NERVE BLOCK UNDER FLUOROSCOPY GUIDANCE</arm_group_label>
    <arm_group_label>NERVE BLOCK UNDER ULTRASOUND GUIDANCE</arm_group_label>
    <other_name>facet joint</other_name>
    <other_name>ultrasound guidance</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>NERVE BLOCK UNDER ULTRASOUND GUIDANCE</intervention_name>
    <description>injection of triamcinolone around the dorsal ramus under ultrasound guidance</description>
    <arm_group_label>FACET JOINT UNDER CT GUIDANCE</arm_group_label>
    <arm_group_label>FACET JOINT UNDER FLUOROSCOPY GUIDANCE</arm_group_label>
    <arm_group_label>FACET JOINT UNDER ULTRASOUND GUIDANCE</arm_group_label>
    <arm_group_label>NERVE BLOCK UNDER CT GUIDANCE</arm_group_label>
    <arm_group_label>NERVE BLOCK UNDER FLUOROSCOPY GUIDANCE</arm_group_label>
    <other_name>dorsal ramus</other_name>
    <other_name>ultrasound guidance</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1- Lumbar facet syndrome diagnosed by the referring specialist: Rehabilitation,
        Traumatology or Neurosurgery 2 -Mechanical low back pain that increases with rotation and
        flexion-extension, without radicular irradiation.

        3- failure of conservative treatment (pharmacological and physical therapy). 4-Symptoms
        present more than 3 months

        Exclusion Criteria:

          1. Previous back surgery and other ablative treatments.

          2. Contraindication for the use of corticosteroid or local anesthetic.

          3. Uncontrolled acute or chronic medical illness.

          4. Pregnancy or lactation.

          5. Presence of inflammatory arthropathy or neuropathy.

          6. Wounds or skin lesions in the area.

          7. Diabetes mellitus.

          8. Psychiatric disorders

          9. Refusal to participate in the study.

         10. Demonstration by imaging techniques of other causes that could justify the
             symptomatology.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>FERNANDO RUIZSANTIAGO, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HOSPITAL DE NEURO-TRAUMATOLOGIA GRANADA (VIRGEN DE LAS NIEVES)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ALBERTO MARTINEZ MARTINEZ, MD</last_name>
    <phone>+34645558225</phone>
    <email>rralbert.martinez@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ana María Del Valle Díaz De La Guardia, MD</last_name>
    <phone>+34958895414</phone>
    <email>anam.valle.sspa@juntadeandalucia.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Complejo Hospitalario Universitario Granada</name>
      <address>
        <city>Granada</city>
        <state>SPA</state>
        <zip>18014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JUANA MARIA DE HARO CASTELLANO</last_name>
      <phone>+34958 020124</phone>
      <email>juanam.haro.exts@juntadeandalucia.es</email>
    </contact>
    <contact_backup>
      <last_name>JUAN MORALES ARCAS</last_name>
      <phone>+34 958 023136</phone>
      <email>juan.morales.sspa@juntadeandalucia.es</email>
    </contact_backup>
    <investigator>
      <last_name>NICOLAS PRADOS OLLETA, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>FERNANDO RUIZ SANTIAGO, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>ALBERTO MARTINEZ MARTINEZ, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>JADE GARCIA ESPINOSA, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Neuro-Traumatologia</name>
      <address>
        <city>Granada</city>
        <zip>1800314</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JUANA MARIA DE HARO CASTELLANO</last_name>
      <phone>+34958 020124</phone>
      <email>juanam.haro.exts@juntadeandalucia.es</email>
    </contact>
    <contact_backup>
      <last_name>JUAN MORALES ARCA</last_name>
      <phone>+34 958 023136</phone>
      <email>juan.morales.sspa@juntadeandalucia.es</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 10, 2019</study_first_submitted>
  <study_first_submitted_qc>March 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2019</study_first_posted>
  <last_update_submitted>March 13, 2019</last_update_submitted>
  <last_update_submitted_qc>March 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Complejo Hospitalario Universitario de Granada</investigator_affiliation>
    <investigator_full_name>FERNANDO RUIZ SANTIAGO</investigator_full_name>
    <investigator_title>PhD, section chief musculoskeletal radiology</investigator_title>
  </responsible_party>
  <keyword>FACET JOINTS</keyword>
  <keyword>FACET INJECTIONS</keyword>
  <keyword>NERVE BLOCK</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthralgia</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>our idea is to publish the short term results and the long term results in order to influence management of this pathology. Tables and statistical analysis will be available for review and metaanalysis.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>1 to 2 years</ipd_time_frame>
    <ipd_access_criteria>open access</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

